Clinuvel Pharmaceuticals
Dr Wright has a broad range of experience in the pharmaceutical industry spanning 25 years. He spent over 17 years at CSL working predominantly in regulatory affairs with nearly a decade as Regulatory Affairs Manager. Most recently he was Global Pharmacovigilance Manager and Regulatory Affairs Manager for the Australian and New Zealand operations of Mayne Pharma, part of Halcygen (ASX:HGN).
He has a Pharmacy degree and post-graduate qualifications from University of Sydney and Health Economics qualifications from Monash University, Melbourne. Dr Wright is responsible for leading the clinical and regulatory development team and progressing afamelanotide through to regulatory approval in global markets.
This person is not in any offices
Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for the general population.